Skip to main content

Envista Holdings Corp

corporate_fare Company Profile

Envista Holdings Corp

NVST·NYSE·Life Sciences·CIK 0001757073

Envista is a global dental products company with over 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. The company provides industry-leading products, solutions, and technology to dental professionals to support patient care. Its portfolio includes dental implants and treatment options, orthodontics, digital imaging technologies, restoratives, endodontics, rotary, infection prevention, and loupes. Envista was formed in 2018 as a wholly-owned subsidiary of Danaher Corporation and completed its initial public offering and separation from Danaher Corporation in 2019. The company serves dental professionals in over 130 countries through its commercial organization and distribution partners. In 2025, Envista generated total sales of $2.7 billion, with approximately 85% derived from sales of consumable products, services, and spare parts. The business operates through two segments: Specialty Products & Technologies, which includes Dental Implant Solutions and Orthodontic Solutions, and Equipment & Consumables, which includes Diagnostic and Consumables Solutions.

Envista Holdings Corp (NYSE:NVST) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 12 items for NVST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for NVST spans FWP, 10-Q, 8-K, DEF 14A.

Recent high-impact activity:

  • Envista Prices $430M of 6.250% Senior Notes Due 2033 to Repay 2028 Term Loan
  • Envista 10-Q Details Q3: $691.5M Sales, $508.3M GAAP Income Inflated by $428.1M Non-Cash FX Gain
  • Envista Tops Q3 Estimates, Lifts FY26 EPS Guidance to $1.54-$1.58
  • Envista Lifts 2026 Guidance as Q3 Buyback and Cash Flow Details Emerge
  • Envista Posts 3Q Adjusted EPS of 40 Cents

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.72B
Net Income
$47M
Diluted EPS
$0.28
Op. Cash Flow
$275.7M
Free Cash Flow
$230.4M
Gross Profit
$1.49B
Operating Income
$216.1M
Cash & Equivalents
$1.21B
Total Debt
$1.45B
Debt / Equity
0.47×
Net Margin
1.7%
Shares Outstanding
163.8M sh
Source: 10-K · filed 2026-02-12 · accession 0001757073-26-000011

Short Interest & Short Volume

2.95 days to cover

FINRA reported short interest of 9,728,394 shares in NVST as of the October 30, 2026 settlement, a 0.5% decrease from the prior period — about 3.0 days to cover at its recent average daily volume. On November 20, 2026, 63.5% of NVST volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,728,394 shares as of October 30, 2026
Change vs prior period▼ 0.5%
Days to cover2.95 at avg daily volume of 3,293,124
Daily short volume (FINRA facilities)63.5% of 717,712 shares on November 20, 2026
5-day average short volume62.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for NVST, detected from its recent SEC filings.

1 shelf registration

Universal Shelf Registered · No Terms, No Proceeds Yet

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with N →
$22.91
52-week range · as of 2026-11-10 $18.77 – $30.42
Market cap
$3.67B
Volume
2.3M (0.7× avg)
3-mo avg 3.2M
Live data · 2026-11-21 14:31 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NVST - Latest Insights

NVST
Nov 10, 2026, 5:26 PM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $25.84
Real-time Price: $22.91 info
Change: -$2.93 (-11%) info
Market Cap: $3.674B info
NVST
Nov 04, 2026, 4:20 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $22.91 info
Change: -$4.28 (-16%) info
Market Cap: $3.674B info
NVST
Nov 04, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $22.91 info
Change: -$4.28 (-16%) info
Market Cap: $3.674B info
NVST
Nov 04, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $22.91 info
Change: -$4.28 (-16%) info
Market Cap: $3.674B info
NVST
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $27.26
Real-time Price: $22.91 info
Change: -$4.35 (-16%) info
Market Cap: $3.674B info
NVST
Aug 05, 2026, 4:40 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $26.90
Real-time Price: $22.91 info
Change: -$3.99 (-15%) info
Market Cap: $3.674B info
NVST
Aug 05, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $26.90
Real-time Price: $22.91 info
Change: -$3.99 (-15%) info
Market Cap: $3.674B info
NVST
May 06, 2026, 4:48 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $28.92
Real-time Price: $22.91 info
Change: -$6.01 (-21%) info
Market Cap: $3.674B info
NVST
May 06, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.11
Real-time Price: $22.91 info
Change: -$7.20 (-24%) info
Market Cap: $3.674B info
NVST
Apr 07, 2026, 4:17 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $25.29
Real-time Price: $22.91 info
Change: -$2.38 (-9%) info
Market Cap: $3.674B info
NVST
Feb 12, 2026, 4:18 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $28.77
Real-time Price: $22.91 info
Change: -$5.86 (-20%) info
Market Cap: $3.674B info
NVST
Feb 05, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.25
Real-time Price: $22.91 info
Change: -$3.34 (-13%) info
Market Cap: $3.674B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets